Hepatitis B clinical trials at UCSD

1 research study open to eligible people

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B
open to eligible people ages 18-70
The purpose of this study is to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations living with HIV: prior HBV vaccine recipients who are deemed non-responders and individuals who are naïve to HBV vaccination.
San Diego, California and other locations

Last updated: March 23, 2022